Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody
Fistulas are common in patients with Crohn's disease and, when associated with inflammatory disease and established for several weeks, tend to be chronic. Perianal fistulas are the most frequent complication of, and are most often associated with, colonic disease. Perianal fistulas commonly req...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2001-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2001/697143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561086373560320 |
|---|---|
| author | Pierre Paré |
| author_facet | Pierre Paré |
| author_sort | Pierre Paré |
| collection | DOAJ |
| description | Fistulas are common in patients with Crohn's disease and, when associated with inflammatory disease and established for several weeks, tend to be chronic. Perianal fistulas are the most frequent complication of, and are most often associated with, colonic disease. Perianal fistulas commonly require surgical resection and permanent ileostomy. Antibiotics, cyclosporine, methotrexate and thalidomide have been used in uncontrolled trials; only azathioprine, 6-mercaptopurine and infliximab have been assessed in double-blind, placebo controlled studies. Relapse of the fistula occurs with all drugs, unless treatment is continued long term. Each drug differs in its onset of action and long term tolerability. An approach to fistulizing disease in Crohn's disease is suggested. |
| format | Article |
| id | doaj-art-5dcd7209bef04628a70d29a425596e7e |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2001-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-5dcd7209bef04628a70d29a425596e7e2025-02-03T01:25:59ZengWileyCanadian Journal of Gastroenterology0835-79002001-01-01151175175610.1155/2001/697143Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to AntibodyPierre Paré0Division of Gastroenterology, Centre Hospitalier Affilie Universitaire de Quebec, Hôpital St-Sacrement, Laval University, Québec, CanadaFistulas are common in patients with Crohn's disease and, when associated with inflammatory disease and established for several weeks, tend to be chronic. Perianal fistulas are the most frequent complication of, and are most often associated with, colonic disease. Perianal fistulas commonly require surgical resection and permanent ileostomy. Antibiotics, cyclosporine, methotrexate and thalidomide have been used in uncontrolled trials; only azathioprine, 6-mercaptopurine and infliximab have been assessed in double-blind, placebo controlled studies. Relapse of the fistula occurs with all drugs, unless treatment is continued long term. Each drug differs in its onset of action and long term tolerability. An approach to fistulizing disease in Crohn's disease is suggested.http://dx.doi.org/10.1155/2001/697143 |
| spellingShingle | Pierre Paré Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody Canadian Journal of Gastroenterology |
| title | Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody |
| title_full | Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody |
| title_fullStr | Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody |
| title_full_unstemmed | Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody |
| title_short | Management of Fistulas in Patients with Crohn'S Disease: Antibiotic to Antibody |
| title_sort | management of fistulas in patients with crohn s disease antibiotic to antibody |
| url | http://dx.doi.org/10.1155/2001/697143 |
| work_keys_str_mv | AT pierrepare managementoffistulasinpatientswithcrohnsdiseaseantibiotictoantibody |